Search results for "Diabetes"
Kidney failure, CV events lower with canagliflozin than placebo, industry study finds
The trial was stopped early after an interim safety analysis found significantly better renal and cardiovascular outcomes among type 2 diabetes patients randomized to canagliflozin than those assigned to placebo.
https://immattersacp.org/weekly/archives/2019/04/23/2.htm
23 Apr 2019
Warning on diabetes drugs, approval of adjuvant flu vaccine
This update covers a warning on sodium-glucose cotransporter-2 inhibitors and approval of a trivalent vaccine for the prevention of seasonal influenza in people age 65 years and older.
https://immattersacp.org/archives/2016/02/fda.htm
1 Feb 2016
New warnings added on multiple diabetes drugs
This update also covers a risk evaluation and mitigation strategy for liraglutide and approval of a new PCSK9 inhibitor.
https://immattersacp.org/archives/2015/11/fda.htm
1 Nov 2015
Phone calls ease isolation during COVID-19
A trial measuring the effect of phone calls to homebound adults early in the pandemic found improvements in loneliness, depression, and anxiety.
https://immattersacp.org/archives/2022/02/phone-calls-ease-isolation-during-covid-19.htm
1 Feb 2022
Cardiovascular events similar, adverse effects worse with chlorthalidone compared to hydrochlorothiazide
Chlorthalidone was associated with a significantly higher risk of hypokalemia, hyponatremia, acute renal failure, chronic kidney disease, type 2 diabetes, and abnormal weight gain.
https://immattersacp.org/weekly/archives/2020/02/25/2.htm
25 Feb 2020
Zolpidem dose for women lowered, diabetes drug approved
This regulatory update covers warnings to lower zolpidem doses in women and approvals for a new drug to improve blood glucose control in adults with type 2 diabetes.
https://immattersacp.org/archives/2013/04/fda.htm
1 Apr 2013
ACC pathway supports neprilysin inhibitor, SGLT-2 inhibitors for heart failure with reduced ejection fraction
The American College of Cardiology (ACC) offered this update to their expert consensus decision pathway from 2017 as interim guidance to physicians while comprehensive updates to heart failure guidelines remain in development.
https://immattersacp.org/weekly/archives/2021/01/26/4.htm
26 Jan 2021
MKSAP Quiz: 6-month history of incontinence
A 68-year-old woman is evaluated for a 6-month history of incontinence typified by continuous leakage and dribbling. Following a physical exam and urinalysis, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2020/12/22/3.htm
22 Dec 2020
New studies analyze risk factors, treatments for afib
One study found that early rhythm control was better than rate control for low-risk patients, another found that age at menarche and menopause was associated with afib risk, and another indicated that women's lower risk for afib is due to their smaller body size compared with men.
https://immattersacp.org/weekly/archives/2022/09/06/1.htm
6 Sep 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/11/latest-updates-on-acps-priorities-initiatives.htm
1 Nov 2022